Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with ...

"Shockwave begins study of IVL catheter for coronary artery lesions" was originally created and published by Medical Device ...

Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s coronary intravascular lithotripsy (IVL) system in a clinical trial. The ...

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Pykus Therapeutics, Inc. ("Pykus" or the "Company") announced today that it has completed enrollment of its pilot study ...

Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...

Medical announced that the FDA has approved an Investigational Device Exemption, IDE, application to initiate a pilot study ...